Your browser doesn't support javascript.
loading
Iron Pathophysiology in Stroke.
Almutairi, Mohammed M A; Xu, Grace; Shi, Honglian.
Afiliación
  • Almutairi MMA; Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS, 66045, USA.
  • Xu G; Department of Pharmacology and Toxicology, School of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
  • Shi H; Department of Anesthesiology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.
Adv Exp Med Biol ; 1173: 105-123, 2019.
Article en En | MEDLINE | ID: mdl-31456207
ABSTRACT
Ischemic and hemorrhagic stroke are the common types of stroke that lead to brain injury neurological deficits and mortality. All forms of stroke remain a serious health issue, and there is little successful development of drugs for treating stroke. Incomplete understanding of stroke pathophysiology is considered the main barrier that limits this research progress. Besides mitochondria and free radical-producing enzymes, labile iron is an important contributor to oxidative stress. Although iron regulation and metabolism in cerebral stroke are not fully understood, much progress has been achieved in recent years. For example, hepcidin has recently been recognized as the principal regulator of systemic iron homeostasis and a bridge between inflammation and iron regulation. This review discusses recent research progress in iron pathophysiology following cerebral stroke, focusing molecular regulation of iron metabolism and potential treatment targets.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Hierro Idioma: En Revista: Adv Exp Med Biol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Hierro Idioma: En Revista: Adv Exp Med Biol Año: 2019 Tipo del documento: Article